Free Republic

A cervical cancer trust is under fire for disgustingly suggesting that people call vaginas “bonus holes” to avoid offending transgender people. Jo’s Cervical Cancer Trust, based in the UK, suggested the language in 2020 — but it just went viral after it was noticed by people and posted to Twitter. “Bonus hole – An alternative word for the vagina. It is important to check which words someone would prefer to use,” the glossary on the trust’s website states. The website claims, “Using the correct language when referring to someone’s gender identity is a simple and effective way to demonstrate support...

For women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progression-free survival, according to a study. Bradley Monk, M.D. and colleagues presented the protocol-specified final overall survival analysis results of KEYNOTE-826, involving eligible adults with persistent, recurrent, or metastatic cervical cancer not previously treated with systemic chemotherapy and not amenable to curative treatment. Participants were randomly assigned to pembrolizumab or placebo for up to 35 cycles plus chemotherapy (paclitaxel, cisplatin, or carboplatin) with or without bevacizumab. A total of 617 patients were randomly assigned (308 to pembrolizumab...

Locally advanced cervical cancer remains an area of high therapeutic need, with recent trials failing to demonstrate evidence of benefit from adjuvant chemotherapy or immune checkpoint blockade administered concurrent with chemoradiation. Results from the NRG-GY017 randomized trial comparing the anti-PD-L1 inhibitor atezolizumab before and concurrent with chemoradiation (CRT) indicated favorable outcomes for 2-year disease-free survival (DFS) and demonstrated evidence of improved immunogenicity with neoadjuvant atezolizumab in patients with locally advanced cervical cancer. NRG-GY017 accrued 36 patients with pelvic or para-aortic lymph-node-positive, locally advanced cervical cancer and randomly assigned patients to receive either atezolizumab prior to and concurrently with CRT on...

Scientists are reporting promising results from a year-long study where soundwaves were used to heat and destroy prostate cancers decade3d/Depositphotos View 2 Images Treating prostate cancer through traditional means such as surgery or radiotherapy carries certain risks, with some patients experiencing impotence, urinary problems and bowel trouble, among other unwanted side effects. Safer and less invasive treatment options could soon be on the table, however, including a novel MRI-guided ultrasound technique that eliminated significant cancers in 80 percent of subjects in a year-long study. The new technique is called MRI-guided transurethral ultrasound ablation (TULSA) and has been under development for...

Hello FReepers. I have long had a problem with the cervical vertebrae in my neck -- the problem manifests as numbness, tingling, and/or pain in my left forearm and left hand. In the past, I have gotten relief from a chiropractor who had a computerized traction table for decompression. He has since sold his practice, and other local chiropractors don't have this equipment. My question: do any of you have personal experience with a home device such as this one? ComforTrac Deluxe Cervical Traction Kit If you do, I'd very much like to hear your feedback about your experience with...

A 23-year-old died of cervical cancer because doctors said she was too young for a smear test, her devastated family have claimed. Mercedes Curnow, from Cornwall, first went to her GP at 20 years old but her mother says her symptoms were 'ignored' because of her age. After a year of doctors visits, Ms Curnow was taken to A&E by a family member and diagnosed with cervical cancer in April 2010. But by then it was too late and, after 33 radiotherapy sessions and nine months of chemotherapy, she died at home in her mother's arms on December 14 last

A sexually transmitted virus is fueling a rise in oral cancer. The HPV virus can cause cancer in the upper throat HPV-positive tumors now account for a majority of these cases. If that trend continues, that type of oral cancer will become the nation's main HPV-related cancer within the decade, surpassing cervical cancer, researchers from Ohio State University and the National Cancer Institute report Monday. Dr. Amy Chen of the American Cancer Society and Emory University, (who wasn't part of the new research), "There is an urgency to try to figure out how to prevent this…No one knows why" Tobacco...

A 14-year-old schoolgirl died hours after being given the controversial cervical cancer vaccine today. The teenager from Blue Coat Church of England School, in Coventry, died in hospital after receiving the Cervarix jab. The tragedy marks the first reported death since more than 1.5m doses of the injection were given to young girls as part of a national vaccination programme since last September in the UK. A number of her classmates have reported side effects to the vaccine. Critics say the case highlights the risks of mass vaccination, because no testing regime can ever pick up the rarest and potentially...

More than 1,300 schoolgirls have experienced adverse reactions to the controversial cervical cancer jab. Doctors have reported that girls aged just 12 and 13 have suffered paralysis,convulsions and sight problems after being given the vaccine. Dozens were described as having pain 'in extremity' while others suffered from nausea, muscle weakness, fever, dizziness and numbness. The vaccine is being given to girls under a Government programme to prevent women from developing cervical cancer.Ministers say it will ultimately save 700 lives a year. Some have dubbed it the 'promiscuity jab' because it is given to girls to protect against the sexually-transmitted HPV...

EIGHT deaths have been linked to the cervical cancer jab which will be given to every 12-year-old girl in Britain under Government plans announced last week. Doctors suspect the jab, which protects against a sexually transmitted human papilloma virus that causes the cancer, may be implicated in 3,461 adverse reactions, including paralysis and seizures. Last week Health Secretary Alan Johnson revealed plans to vaccinate all girls aged between 12 and 13 to cut Britain’s death rate from the disease. He said: “Prevention is better than cure and this vaccine will prevent many women from catching the virus in the first...

The D.C. Council opened its legislative year by introducing a bill that could make the District one of the first jurisdictions in the country to require girls younger than 13 years old to get a new nationally debated vaccine against cervical cancer. Female students enrolling in the sixth grade would be asked to show proof of receiving the vaccine against the sexually transmitted human papilloma virus (HPV) under the bill, introduced yesterday by council members David A. Catania (I-At Large) and Mary M. Cheh (D-Ward 3). A parent or legal guardian would have the right to "opt out" of the...

Cervical cancer virus risk may depend on race 15:30 02 August 2006 NewScientist.com news service Roxanne Khamsi Race may influence a woman’s risk of a virus known to cause cervical cancer, researchers report. The new study finds that a variant of the human papillomavirus (HPV) from a particular geographical region will infect a woman longer if her ancestors come from the same region. Experts say it is an uncommon example of how people are more prone to viral agents from their own place of origin. HPV is by no means an uncommon virus: about 50% of sexually active women between...

Medicine usually progresses in incremental steps. One antidepressant or cholesterol-lowering drug follows another with only marginally improved therapeutic benefit. Vaccines are different. Disease prevention through immunization, whether for polio or mumps, has the potential to transform medical practice, sometimes eliminating illness altogether. Smallpox is now (we hope) confined to heavily protected freezers in Russia and at the Centers for Disease Control and Prevention in Atlanta. Vaccine developers appear to be on the verge of another remarkable achievement. Two vaccines that are nearing approval by the Food and Drug Administration in the U.S.--one from Merck, the other from Glaxo­SmithKline--have demonstrated in...